BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 3509916)

  • 1. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.
    Tite JP; Sloan A; Janeway CA
    J Mol Cell Immunol; 1986; 2(4):179-90. PubMed ID: 3509916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of antibodies to Lyt-2 and L3T4 on cytolysis by cloned, Ia-restricted T cells expressing both proteins.
    Jones B; Khavari PA; Conrad PJ; Janeway CA
    J Immunol; 1987 Jul; 139(2):380-4. PubMed ID: 3110269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the murine L3T4 molecule in T cell activation: differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies.
    Janeway CA; Haque S; Smith LA; Saizawa K
    J Mol Cell Immunol; 1987; 3(2):121-31. PubMed ID: 2978238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
    Owens T; Fazekas de St Groth B
    J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective activation of resting mouse T lymphocytes by cross-linking submitogenic concentrations of the T cell antigen receptor with either Lyt-2 or L3T4.
    Eichmann K; Jönsson JI; Falk I; Emmrich F
    Eur J Immunol; 1987 May; 17(5):643-50. PubMed ID: 3108015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4-Ia interactions can occur in the absence of T-cell receptor/antigen-Ia recognition.
    Andris F; Leo O; Van Mechelen M; Urbain J; Slaoui M
    Immunology; 1989 Sep; 68(1):1-6. PubMed ID: 2530152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of accessory molecules in signal transduction of cytolytic T lymphocyte by anti-T cell receptor and anti-Ly-6.2C monoclonal antibodies.
    Leo O; Foo M; Henkart PA; Perez P; Shinohara N; Segal DM; Bluestone JA
    J Immunol; 1987 Dec; 139(11):3556-63. PubMed ID: 3316387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
    Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
    J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the L3T4-antigen in T cell activation. II. Inhibition of T cell activation by monoclonal anti-L3T4 antibodies in the absence of accessory cells.
    Wassmer P; Chan C; Lögdberg L; Shevach EM
    J Immunol; 1985 Oct; 135(4):2237-42. PubMed ID: 3897371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of valence on the functional activities of monoclonal anti-L3T4 antibodies. Discrimination of signaling from other effects.
    Haque S; Saizawa K; Rojo J; Janeway CA
    J Immunol; 1987 Nov; 139(10):3207-12. PubMed ID: 2960730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct roles for L3T4 in T cell activation.
    Greenstein JL; Sitkovsky MV; Burakoff SJ
    Fed Proc; 1987 Feb; 46(2):313-6. PubMed ID: 3492395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accessory molecules and T cell activation. II. Antibody binding to L3T4a inhibits Ia-independent mouse T cell proliferation.
    Pont S; Régnier-Vigouroux A; Marchetto S; Pierres M
    Eur J Immunol; 1987 Mar; 17(3):429-32. PubMed ID: 3106063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of stimulation of T cells by the Mycoplasma arthritidis-derived mitogen. Role of class II IE molecules.
    Bekoff MC; Cole BC; Grey HM
    J Immunol; 1987 Nov; 139(10):3189-94. PubMed ID: 3500207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of accessory cell and T cell surface antigens on mitogen-induced IL 2 receptor expression.
    Malek TR; Chan C; Glimcher LH; Germain RN; Shevach EM
    J Immunol; 1985 Sep; 135(3):1826-33. PubMed ID: 3926885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of L3T4 and Ia in the heteroclitic response of T cells to cytochrome c.
    Lakey EK; Margoliash E; Fitch FW; Pierce SK
    J Immunol; 1986 Jun; 136(11):3933-8. PubMed ID: 2422265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two roles for Ia in antigen-specific T lymphocyte activation.
    Kim KH; Shivdasani RA; Thomas DW
    J Immunol; 1986 Dec; 137(11):3393-400. PubMed ID: 3491135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
    J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Search for class II major histocompatibility complex molecular involvement in the response of Lyt-2+ cytotoxic T lymphocyte precursors to alloantigen.
    Romani L; Mage MG
    Eur J Immunol; 1985 Nov; 15(11):1125-30. PubMed ID: 2933265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.